Determinants of any incident asymptomatic chlamydia, gonorrhoea or syphilis among PrEP users, AMPrEP cohort study, August 2015–February 2020, Amsterdam, the Netherlands
# events | Person-years | Univariable Poisson model | Multivariable Poisson model | |||||
IRR | 95% CI | P value | aIRR | 95% CI | P value | |||
Years since PrEP initiation | ||||||||
1 | 199 | 359 | Ref | 0.763 | Ref | |||
2 | 169 | 338 | 0.90 | 0.73 to 1.11 | 0.94 | 0.76 to 1.15 | 0.532 | |
3 | 171 | 320 | 0.97 | 0.79 to 1.19 | 1.08 | 0.87 to 1.33 | 0.491 | |
4 | 132 | 259 | 0.92 | 0.74 to 1.15 | 1.09 | 0.84 to 1.41 | 0.517 | |
Age, per 10-year increase* | 0.87 | 0.81 to 0.93 | <0.001 | 0.86 | 0.80 to 0.92 | <0.001 | ||
Age* | ||||||||
<35 years | 191 | 308 | Ref | <0.001 | ||||
35–44 years | 246 | 413 | 0.96 | 0.79 to 1.16 | ||||
≥45 years | 256 | 582 | 0.71 | 0.59 to 0.86 | ||||
Self-declared ethnicity† | ||||||||
White | 595 | 1117 | Ref | 0.932 | ||||
Non-white | 98 | 186 | 0.99 | 0.80 to 1.23 | ||||
Highest education level† | ||||||||
No college/university | 129 | 286 | Ref | 0.029 | ||||
College/university | 564 | 1016 | 1.23 | 1.02 to 1.49 | ||||
Employment† | ||||||||
Unemployed | 142 | 279 | Ref | 0.507 | ||||
Employed | 544 | 1006 | 1.06 | 0.88 to 1.28 | ||||
Sexual preference† | ||||||||
Exclusively homosexual | 564 | 1029 | Ref | 0.165 | ||||
Not exclusively homosexual | 129 | 269 | 0.87 | 0.72 to 1.06 | ||||
CAS with a steady partner* | ||||||||
No | 413 | 748 | Ref | 0.360 | ||||
Yes | 259 | 504 | 0.93 | 0.80 to 1.09 | ||||
CAS with a known casual partner* | ||||||||
No | 125 | 347 | Ref | <0.001 | Ref | 0.004 | ||
Yes | 547 | 906 | 1.67 | 1.38 to 2.03 | 1.36 | 1.10 to 1.68 | ||
CAS with an unknown casual partner* | ||||||||
No | 105 | 331 | Ref | <0.001 | Ref | <0.001 | ||
Yes | 567 | 922 | 1.94 | 1.57 to 2.39 | 1.86 | 1.48 to 2.34 | ||
Chemsex*‡ | ||||||||
No | 283 | 690 | Ref | <0.001 | Ref | <0.001 | ||
Yes | 339 | 477 | 1.73 | 1.48 to 2.03 | 1.51 | 1.28 to 1.78 | ||
Alcohol Use Disorder Identification Test*§ | ||||||||
Score <8 | 493 | 884 | Ref | 0.049 | ||||
Score ≥8 | 129 | 280 | 0.83 | 0.68 to 1.00 | ||||
Drug Use Disorder Identification Test*§ | ||||||||
Score <8 | 395 | 802 | Ref | 0.004 | ||||
Score ≥8 | 227 | 362 | 1.28 | 1.08 to 1.50 | ||||
MHI-5*¶ | ||||||||
Score ≥60 | 504 | 939 | Ref | 0.842 | ||||
Score <60 | 117 | 222 | 0.98 | 0.80 to 1.20 | ||||
Sexual Compulsivity Scale score*** | ||||||||
Score <24 | 535 | 1021 | Ref | 0.180 | ||||
Score ≥24 | 86 | 140 | 1.17 | 0.93 to 1.47 |
*Time updated.
†As reported at baseline.
‡Defined as any gamma-hydroxybutyrate/gamma-butyrolactone, crystallised methamphetamine or mephedrone use during sex.
§A score of 8 or higher indicates possible presence of alcohol or drug use disorder.
¶A score lower than 60 indicates possible mood or depressive mood disorder.
**A score or 24 or higher indicates a greater impact of sexual thoughts on daily functioning and an inability to control sexual thoughts or behaviour.
aIRR, adjusted incidence rate ratio; AMPrEP, Amsterdam PrEP demonstration project; CAS, condomless anal sex; IRR, incidence rate ratio; MHI-5, Mental Health Inventory screening test; PrEP, pre-exposure prophylaxis.